Skip to main content
PMC home page
Gut logoLink to Gut
. 1997 Dec;41(6):728–730. doi: 10.1136/gut.41.6.728

Vaccine against Helicobacter pylori: fact or fiction?

P MICHETTI 1
PMCID: PMC1891600  PMID: 9462202

Full Text

The Full Text of this article is available as a PDF (79.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chen M., Lee A., Hazell S. Immunisation against gastric helicobacter infection in a mouse/Helicobacter felis model. Lancet. 1992 May 2;339(8801):1120–1121. doi: 10.1016/0140-6736(92)90720-n. [DOI] [PubMed] [Google Scholar]
  2. Corthésy-Theulaz I., Porta N., Glauser M., Saraga E., Vaney A. C., Haas R., Kraehenbuhl J. P., Blum A. L., Michetti P. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology. 1995 Jul;109(1):115–121. doi: 10.1016/0016-5085(95)90275-9. [DOI] [PubMed] [Google Scholar]
  3. Cuenca R., Blanchard T. G., Czinn S. J., Nedrud J. G., Monath T. P., Lee C. K., Redline R. W. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology. 1996 Jun;110(6):1770–1775. doi: 10.1053/gast.1996.v110.pm8964402. [DOI] [PubMed] [Google Scholar]
  4. Czinn S. J., Cai A., Nedrud J. G. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine. 1993;11(6):637–642. doi: 10.1016/0264-410x(93)90309-l. [DOI] [PubMed] [Google Scholar]
  5. Dickinson B. L., Clements J. D. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun. 1995 May;63(5):1617–1623. doi: 10.1128/iai.63.5.1617-1623.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Doidge C., Crust I., Lee A., Buck F., Hazell S., Manne U. Therapeutic immunisation against Helicobacter infection. Lancet. 1994 Apr 9;343(8902):914–915. doi: 10.1016/s0140-6736(94)90032-9. [DOI] [PubMed] [Google Scholar]
  7. Fendrick A. M., Chernew M. E., Hirth R. A., Bloom B. S. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med. 1995 Aug 15;123(4):260–268. doi: 10.7326/0003-4819-123-4-199508150-00003. [DOI] [PubMed] [Google Scholar]
  8. Ferrero R. L., Thiberge J. M., Kansau I., Wuscher N., Huerre M., Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6499–6503. doi: 10.1073/pnas.92.14.6499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fox J. G., Otto G., Taylor N. S., Rosenblad W., Murphy J. C. Helicobacter mustelae-induced gastritis and elevated gastric pH in the ferret (Mustela putorius furo). Infect Immun. 1991 Jun;59(6):1875–1880. doi: 10.1128/iai.59.6.1875-1880.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gilvarry J., Buckley M. J., Beattie S., Hamilton H., O'Morain C. A. Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol. 1997 Jun;32(6):535–540. doi: 10.3109/00365529709025095. [DOI] [PubMed] [Google Scholar]
  11. Jorgensen M., Daskalopoulos G., Warburton V., Mitchell H. M., Hazell S. L. Multiple strain colonization and metronidazole resistance in Helicobacter pylori-infected patients: identification from sequential and multiple biopsy specimens. J Infect Dis. 1996 Sep;174(3):631–635. doi: 10.1093/infdis/174.3.631. [DOI] [PubMed] [Google Scholar]
  12. Kozlowski P. A., Cu-Uvin S., Neutra M. R., Flanigan T. P. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun. 1997 Apr;65(4):1387–1394. doi: 10.1128/iai.65.4.1387-1394.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kreiss C., Buclin T., Cosma M., Corthésy-Theulaz I., Michetti P. Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection. Lancet. 1996 Jun 8;347(9015):1630–1631. doi: 10.1016/s0140-6736(96)91119-8. [DOI] [PubMed] [Google Scholar]
  14. Lee J., O'Morain C. Consensus or confusion: a review of existing national guidelines on Helicobacter pylori-related disease. Eur J Gastroenterol Hepatol. 1997 May;9(5):527–531. doi: 10.1097/00042737-199705000-00021. [DOI] [PubMed] [Google Scholar]
  15. Marchetti M., Aricò B., Burroni D., Figura N., Rappuoli R., Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science. 1995 Mar 17;267(5204):1655–1658. doi: 10.1126/science.7886456. [DOI] [PubMed] [Google Scholar]
  16. Marshall B. J. The future of Helicobacter pylori eradication: a personal perspective. Aliment Pharmacol Ther. 1997 Apr;11 (Suppl 1):109–115. doi: 10.1046/j.1365-2036.11.s1.14.x. [DOI] [PubMed] [Google Scholar]
  17. Michetti P., Corthésy-Theulaz I., Davin C., Haas R., Vaney A. C., Heitz M., Bille J., Kraehenbuhl J. P., Saraga E., Blum A. L. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology. 1994 Oct;107(4):1002–1011. doi: 10.1016/0016-5085(94)90224-0. [DOI] [PubMed] [Google Scholar]
  18. Midolo P. D., Lambert J. R., Turnidge J. Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy. J Gastroenterol Hepatol. 1996 Mar;11(3):290–292. doi: 10.1111/j.1440-1746.1996.tb00078.x. [DOI] [PubMed] [Google Scholar]
  19. Minota S. [Autoimmune diseases and stress proteins]. Rinsho Byori. 1997 Jan;45(1):19–26. [PubMed] [Google Scholar]
  20. Noach L. A., Langenberg W. L., Bertola M. A., Dankert J., Tytgat G. N. Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis. 1994;26(3):321–327. doi: 10.3109/00365549409011802. [DOI] [PubMed] [Google Scholar]
  21. Ofman J. J., Etchason J., Fullerton S., Kahn K. L., Soll A. H. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences. Ann Intern Med. 1997 Feb 15;126(4):280–291. doi: 10.7326/0003-4819-126-4-199702150-00004. [DOI] [PubMed] [Google Scholar]
  22. Silverstein M. D., Petterson T., Talley N. J. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology. 1996 Jan;110(1):72–83. doi: 10.1053/gast.1996.v110.pm8536890. [DOI] [PubMed] [Google Scholar]
  23. Sonnenberg A. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects. Am J Gastroenterol. 1996 Sep;91(9):1773–1777. [PubMed] [Google Scholar]
  24. Stadtländer C. T., Gangemi J. D., Khanolkar S. S., Kitsos C. M., Farris H. E., Jr, Fulton L. K., Hill J. E., Huntington F. K., Lee C. K., Monath T. P. Immunogenicity and safety of recombinant Helicobacter pylori urease in a nonhuman primate. Dig Dis Sci. 1996 Sep;41(9):1853–1862. doi: 10.1007/BF02088757. [DOI] [PubMed] [Google Scholar]
  25. Telford J. L., Ghiara P., Dell'Orco M., Comanducci M., Burroni D., Bugnoli M., Tecce M. F., Censini S., Covacci A., Xiang Z. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med. 1994 May 1;179(5):1653–1658. doi: 10.1084/jem.179.5.1653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. van der Hulst R. W., van der Ende A., Dekker F. W., Ten Kate F. J., Weel J. F., Keller J. J., Kruizinga S. P., Dankert J., Tytgat G. N. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology. 1997 Jul;113(1):25–30. doi: 10.1016/s0016-5085(97)70076-3. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES